ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
2d agoen
From the article
Conditions : Stroke, Acute Ischemic; Endovascular Thrombectomy; Acute Ischemic Stroke AIS Interventions : Biological: Tenecteplase or Alteplase- depending upon availability at each treating centre; Other: Control Sponsors : University of Calgary; The George Institute for Global Health, Australia Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
HKUMed develops world-first NanoPowder nasal spray for prehospital ischemic stroke treatment
A research team from HKUMed and InnoHK ABIC has developed the world's first 'NanoPowder nasal spray' for ischemic stroke. This innovation ov
biospectrumasia.com·1mo ago
Post-stroke acute heart failure in large vessel occlusion patients undergoing endovascular treatment: A pooled analysis of individual patient data
This pooled analysis of individual patient data from multicenter studies investigates the incidence, predictors, and impact of post-stroke a
plos.io·14h ago
New plasma proteomics model improves thrombosis risk prediction in cancer patients and identifies IL-17-driven endothelial activation as therapeutic target
This article presents research by Karagkouni and colleagues who developed a new cancer-associated venous thromboembolism (VTE) prediction mo
scim.ag·16d ago
Ondas de choque e balão: hospital brasileiro testa com sucesso novo tratamento para desobstruir placas de gordura nos vasos
Extra Online·1d ago
Acute versus Long-term anti-GPVI Treatment: From Receptor Blockade to Partial Downregulation
communities.springernature.com·18h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.